A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Inclusion criteria

• Age ≥ 18 years or older
• Karnofsky score 60 or greater
• Life expectancy greater than six months
• English speaking
• Additional Inclusion Criteria for Head and Neck, Thoracic, Gynecologic, Melanoma and Breast Baskets
• Patients with a diagnosis of head and neck tumors, thoracic tumors, gynecological tumors, melanoma, breast cancer, or gynecologic cancer
• Actively receiving systemic oncological treatment or radiotherapy, or within 4 weeks of radiotherapy completion or primary cytoreductive surgery
• Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)
• Additional Inclusion Criteria for First Remission Gynecologic Cancer Basket
• Patients with a diagnosis or clinical suspicion of gynecologic malignancy who have completed definitive first line treatment (maintenance hormonal or targeted therapies are allowed)
• Additional Inclusion Criteria for the Advanced Cancer Basket:
• Patients with a diagnosis of Stage III or IV lung cancer; any stage pancreatic cancer, unresectable cholangiocarcinoma, unresectable liver cancer, unresectable ampullary or peri-ampullary cancer, or other stage IV gastrointestinal cancer; stage III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer; stage IV breast cancer; stage III testicular cancer or any stage IV genitourinary cancer; stage IV sarcoma; stage IV melanoma; stage IV endocrine cancer; lymphoma, myeloma, or Leukemia
• Actively receiving oncological treatment, radiotherapy or active surveillance
• Additional Inclusion Criteria for the Cancer Survivor Basket:
• Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) (maintenance hormonal or targeted therapies are allowed).
• Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)

Exclusion criteria

• Cognitive impairment that would preclude response to study assessments or require the use of Legally Authorized Representatives
• Unwilling to accept random assignment
• Concurrently enroll onto ongoing competing trials of integrative medicine interventions with symptom/toxicity as primary outcome. Note, however, patient will be allowed to enroll on other therapeutic protocols